Product NDC: | 55390-281 |
Proprietary Name: | Cerubidine |
Non Proprietary Name: | daunorubicin hydrochloride |
Active Ingredient(s): | 20 mg/4mL & nbsp; daunorubicin hydrochloride |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, POWDER, FOR SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 55390-281 |
Labeler Name: | Bedford Laboratories |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA064103 |
Marketing Category: | ANDA |
Start Marketing Date: | 19980601 |
Package NDC: | 55390-281-10 |
Package Description: | 10 VIAL in 1 BOX (55390-281-10) > 4 mL in 1 VIAL |
NDC Code | 55390-281-10 |
Proprietary Name | Cerubidine |
Package Description | 10 VIAL in 1 BOX (55390-281-10) > 4 mL in 1 VIAL |
Product NDC | 55390-281 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | daunorubicin hydrochloride |
Dosage Form Name | INJECTION, POWDER, FOR SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 19980601 |
Marketing Category Name | ANDA |
Labeler Name | Bedford Laboratories |
Substance Name | DAUNORUBICIN HYDROCHLORIDE |
Strength Number | 20 |
Strength Unit | mg/4mL |
Pharmaceutical Classes | Anthracycline Topoisomerase Inhibitor [EPC],Anthracyclines [Chemical/Ingredient],Topoisomerase Inhibitors [MoA] |